TwoStep Therapeutics
A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors.
$62.5MSeries A
Role not disclosedSU
Stanford University
Activity from announced rounds
Activity in this selectionOct 18, 2026 · Jul 21, 2026
Stanford University is the academic investor explicitly identified by GridCARE, Deepgram and TwoStep.
Recorded funding activity
GridCARE analyzes grid capacity. Deepgram supplies voice APIs, while TwoStep develops targeted cancer therapies. The announcements identify university participation separately from faculty founders, affiliation and licensing.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $62.5M 1 disclosed · full round size, not this investor’s share